CTCBIO Inc. (KOSDAQ:060590)

South Korea flag South Korea · Delayed Price · Currency is KRW
4,440.00
-30.00 (-0.67%)
At close: Jan 29, 2026
-42.11%
Market Cap106.15B
Revenue (ttm)132.76B -4.5%
Net Income2.64B
EPS110.61
Shares Out23.91M
PE Ratio40.02
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume136,323
Average Volume73,419
Open4,470.00
Previous Close4,470.00
Day's Range4,350.00 - 4,475.00
52-Week Range4,225.00 - 7,840.00
Beta-0.10
RSI43.78
Earnings DateMar 20, 2026

About CTCBIO

CTCBIO Inc. provides various pharmaceutical products in South Korea and internationally. The company offers animal and human pharmaceuticals; feed additives and ingredients; and functional food products. It also provides cardiovascular, gastrointestinal, osteoporosis, antibiotic, smoking cessation, antifungal and antiviral, antiepileptic, allergic rhinitis, dermatology and genito-urinory, allergic rhinitis and antihistamine, neuropsychiarty, intestinal disorders, X-ray, diabetes, anti-inflammatory and arthritis, and harmones, as well as CTC cov... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 1993
Employees 248
Stock Exchange KOSDAQ
Ticker Symbol 060590
Full Company Profile

Financial Performance

In 2024, CTCBIO's revenue was 144.41 billion, an increase of 4.74% compared to the previous year's 137.88 billion. Losses were -5.22 billion, -66.51% less than in 2023.

Financial Statements